Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolcapone genotype-based cognitive enhancement in schizophrenia
2010-024119-15Phase 2Recruiting
- Sponsor
- Clínica Universidad de Navarra
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of tolcapone in schizophrenia (2 cohorts), sponsored by Clínica Universidad de Navarra. Primary endpoints: DPX cognitive test performance and Functional neuroimaging brain activation. Started Apr 2014; status: recruiting.
02
Drugs
tolcapone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2010-024119-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024119-15.